New cholesterol pill may help those who can't tolerate statins
NCT ID NCT07239414
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests bempedoic acid, a daily pill that lowers bad cholesterol, against statins in about 690 adults aged 40 and older who have high cholesterol but no history of heart attack or stroke. Participants must have had trouble sticking with statins due to side effects or other reasons. The goal is to see if bempedoic acid works better and is easier to tolerate, while also checking for side effects like gout or liver issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Putting Patients' priorities first: a new approach to ease the burden of multiple chronic illnesses
- 4,500 healthy adults tracked to uncover hidden disease risks
- Fitbit for the heart: tiny tracker may speed recovery after surgery
- CRISPR therapy takes aim at stubborn high cholesterol in first human trial
- New blood tests could speed up disease detection
- Million-Person african study aims to fill health data gap